Extra‐cellular matrix in vascular networks

Abstract.  The vascular network is a series of linked conduits of blood vessels composed of the endothelium, a monolayer of cells that adorn the vessel lumen and surrounding layer(s) of mesenchymal cells (vascular smooth muscle, pericytes and fibroblasts). In addition to providing structural support, the mesenchymal cells are essential for vessel contractility. The extracellular matrix is a major constituent of blood vessels and provides a framework in which these various cell types are attached and embedded. The composition and organization of vascular extracellular matrix is primarily controlled by the mesenchymal cells, and is also responsible for the mechanical properties of the vessel wall, forming complex networks of structural proteins which are highly regulated. The extracellular matrix also plays a central role in cellular adhesion, differentiation and proliferation. This review examines the cellular and extracellular matrix components of vessels, with specific emphasis on the regulation of collagen type I and implications in vascular disease.

[1]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[2]  D. Abraham,et al.  Col1a2 enhancer regulates collagen activity during development and in adult tissue repair. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[3]  A. Bobik,et al.  Metalloproteinases and plasminogen activators in vessel remodeling , 2003, Current hypertension reports.

[4]  Dean Y. Li,et al.  New insights into elastin and vascular disease. , 2003, Trends in cardiovascular medicine.

[5]  E. Creemers,et al.  The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis , 2003, The Journal of pathology.

[6]  G. Gabbiani,et al.  The myofibroblast in wound healing and fibrocontractive diseases , 2003, The Journal of pathology.

[7]  A. Newby,et al.  Regulation of Matrix Metalloproteinase (Matrixin) Genes in Blood Vessels: A Multi-Step Recruitment Model for Pathological Remodelling , 2003, Journal of Vascular Research.

[8]  R. Kalluri.  Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.

[9]  S. Schwartz,et al.  Expression Profiling Identifies 147 Genes Contributing to a Unique Primate Neointimal Smooth Muscle Cell Phenotype , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[10]  Z. Galis,et al.  Targeted Disruption of the Matrix Metalloproteinase-9 Gene Impairs Smooth Muscle Cell Migration and Geometrical Arterial Remodeling , 2002, Circulation research.

[11]  R. Virmani,et al.  Differential Accumulation of Proteoglycans and Hyaluronan in Culprit Lesions: Insights Into Plaque Erosion , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[12]  G. Pasterkamp,et al.  Matrix metalloproteinase inhibition reduces adventitial thickening and collagen accumulation following balloon dilation. , 2002, Cardiovascular research.

[13]  V. Fuster,et al.  Intimomedial Interface Damage and Adventitial Inflammation Is Increased Beneath Disrupted Atherosclerosis in the Aorta: Implications for Plaque Vulnerability , 2002, Circulation.

[14]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[15]  M. Makuuchi,et al.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.

[16]  B. Strauss,et al.  Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. , 2002, The American journal of pathology.

[17]  K. Alitalo,et al.  Vascular growth factors and lymphangiogenesis. , 2002, Physiological reviews.

[18]  A. Chiavegato,et al.  Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant , 2001, Circulation research.

[19]  M. Witte,et al.  Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology , 2001, Microscopy research and technique.

[20]  K. Williams,et al.  Arterial wall chondroitin sulfate proteoglycans: diverse molecules with distinct roles in lipoprotein retention and atherogenesis , 2001, Current opinion in lipidology.

[21]  L. Sakai,et al.  Regulation of limb patterning by extracellular microfibrils , 2001, The Journal of cell biology.

[22]  S. Phan,et al.  Regulation of alpha-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts. , 2001, The international journal of biochemistry & cell biology.

[23]  C. Denton,et al.  Characterization of an Evolutionarily Conserved Far-upstream Enhancer in the Human α2(I) Collagen (COL1A2) Gene* , 2001, The Journal of Biological Chemistry.

[24]  H. Lijnen.  Extracellular proteolysis in the development and progression of atherosclerosis. , 2001, Biochemical Society transactions.

[25]  R. Virmani,et al.  Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with 'healthy' subjects dying out of hospital. , 2001, Atherosclerosis.

[26]  C. Denton,et al.  Activation of a fibroblast-specific enhancer of the proalpha2(I) collagen gene in tight-skin mice. , 2001, Arthritis and rheumatism.

[27]  E. Camenzind,et al.  Mechanisms of Neointima Formation and Remodeling in the Porcine Coronary Artery , 2001, Circulation.

[28]  D. Sims.  Diversity Within Pericytes , 2000, Clinical and experimental pharmacology & physiology.

[29]  U. Schlötzer-Schrehardt,et al.  Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture. , 2000, Kidney international.

[30]  V. Petrov,et al.  Induction of cardiac fibrosis by transforming growth factor-beta(1). , 2000, Molecular genetics and metabolism.

[31]  K. Weber,et al.  Connective tissue and the heart. Functional significance and regulatory mechanisms. , 2000, Cardiology clinics.

[32]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[33]  F. Ramirez,et al.  Elastic and collagenous networks in vascular diseases. , 2000, Cell structure and function.

[34]  M. Rekhter,et al.  Hypercholesterolemia causes mechanical weakening of rabbit atheroma : local collagen loss as a prerequisite of plaque rupture. , 2000, Circulation research.

[35]  Z. Galis.  Atheroma morphology and mechanical strength: looks are important, after all--lose the fat. , 2000, Circulation research.

[36]  M. Radomski,et al.  Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. , 1999, Circulation research.

[37]  M. Daemen,et al.  The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. , 1999, Cardiovascular research.

[38]  G. Gabbiani,et al.  Mechanisms of myofibroblast activity and phenotypic modulation. , 1999, Experimental cell research.

[39]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[40]  S. Kaul,et al.  Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. , 1999, Circulation.

[41]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[42]  M. Schäfer,et al.  Angiogenesis in the Bovine Corpus Luteum: An Immunocytochemical and Ultrastructural Study* , 1999, Anatomia, histologia, embryologia.

[43]  P. Libby,et al.  Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. , 1999, Circulation.

[44]  M. Rabinovitch,et al.  Induction of vascular smooth muscle cell tenascin-C gene expression by denatured type I collagen is dependent upon a beta3 integrin-mediated mitogen-activated protein kinase pathway and a 122-base pair promoter element. , 1999, Journal of cell science.

[45]  A. Newby,et al.  Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. , 1999, Cardiovascular research.

[46]  M. Rekhter,et al.  Collagen synthesis in atherosclerosis: too much and not enough. , 1999, Cardiovascular research.

[47]  C. Little,et al.  Developmental Biology of the Vascular Smooth Muscle Cell: Building a Multilayered Vessel Wall , 1999, Journal of Vascular Research.

[48]  T. Inomata,et al.  Collagen fiber arrangement in canine hepatic venules. , 1999, The Journal of veterinary medical science.

[49]  P. Greenwel,et al.  Activation of Proalpha2(I) collagen promoter during hepatic fibrogenesis in transgenic mice. , 1998, Biochemical and biophysical research communications.

[50]  R. Ardaillou,et al.  Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin. , 1998, The Journal of clinical investigation.

[51]  Dean Y. Li,et al.  Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.

[52]  P L Weissberg,et al.  Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[53]  W. Denetclaw,et al.  Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. , 1998, Developmental biology.

[54]  R R Markwald,et al.  Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. , 1997, Circulation research.

[55]  M. Daemen,et al.  A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart , 1997, Nature Medicine.

[56]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[57]  S. Grieshaber,et al.  Developmental regulation of perlecan gene expression in aortic smooth muscle cells. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[58]  W. Parks,et al.  Role of Matrix Metalloproteinases in Abdominal Aortic Aneurysms a , 1996, Annals of the New York Academy of Sciences.

[59]  S. Shapiro,et al.  Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  K. Niederreither,et al.  A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice , 1996, The Journal of cell biology.

[61]  C. Lethias,et al.  Composition and organization of the extracellular matrix of vein walls: collagen networks. , 1996, International angiology : a journal of the International Union of Angiology.

[62]  R. Timpl,et al.  Fibulin‐1 and fibulin‐2 expression during organogenesis in the developing mouse embryo , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[63]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[64]  M. Daemen,et al.  Collagen remodeling after myocardial infarction in the rat heart. , 1995, The American journal of pathology.

[65]  B. Crombrugghe,et al.  Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice , 1995, The Journal of cell biology.

[66]  M. Daemen,et al.  The alpha-smooth muscle actin-positive cells in healing human myocardial scars. , 1994, The American journal of pathology.

[67]  M. Reed,et al.  Cell-specific expression of alpha 1(I) collagen-hGH minigenes in transgenic mice , 1994, The Journal of cell biology.

[68]  B. Sokolov,et al.  Regulation of the alpha 1(I) collagen promoter in vascular smooth muscle cells. Comparison with other alpha 1(I) collagen-producing cells in transgenic animals and cultured cells. , 1994, The Journal of biological chemistry.

[69]  D. Rowe,et al.  Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[70]  P. Libby,et al.  Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic Lesions a , 1994, Annals of the New York Academy of Sciences.

[71]  R. Hynes,et al.  Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. , 1993, Development.

[72]  J. Rosenbloom,et al.  Developmental regulation of aortic elastin gene expression involves disruption of an IGF-I sensitive repressor complex. , 1993, Biochemical and biophysical research communications.

[73]  G. Baumbach,et al.  Mechanics and composition of cerebral arterioles in renal and spontaneously hypertensive rats. , 1993, Hypertension.

[74]  V. Koteliansky,et al.  Laminin variants and integrin laminin receptors in developing and adult human smooth muscle. , 1993, Developmental biology.

[75]  K. Niederreither,et al.  Minimal DNA sequences that control the cell lineage-specific expression of the pro alpha 2(I) collagen promoter in transgenic mice , 1992, The Journal of cell biology.

[76]  V Nehls,et al.  Heterogeneity of microvascular pericytes for smooth muscle type alpha- actin , 1991, The Journal of cell biology.

[77]  R. Gutiérrez,et al.  Microvascular pericytes: a review of their morphological and functional characteristics. , 1991, Histology and histopathology.

[78]  P. Bornstein,et al.  An upstream regulatory region mediates high-level, tissue-specific expression of the human alpha 1(I) collagen gene in transgenic mice , 1991, Molecular and cellular biology.

[79]  H. Bouissou,et al.  Collagen of the normal and the varicose human saphenous vein: a biochemical study. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[80]  J. Campbell,et al.  Smooth muscle phenotypic expression in human carotid arteries. II. Atherosclerosis-free diffuse intimal thickenings compared with the media. , 1986, Arteriosclerosis.

[81]  J. Jerdan,et al.  Retinal microvessel extracellular matrix: an immunofluorescent study. , 1986, Investigative ophthalmology & visual science.

[82]  R. Jaenisch,et al.  Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death , 1984, Cell.

[83]  J. Rhodin,et al.  Ultrastructure of mammalian venous capillaries, venules, and small collecting veins. , 1968, Journal of ultrastructure research.

[84]  E. Schleicher,et al.  Identification of lymph and blood capillaries by immunohistochemical staining for various basement membrane components , 2004, Histochemistry.

[85]  D. Schwartz,et al.  Tumor invasion and host extracellular matrix , 2004, Cancer and Metastasis Reviews.

[86]  Z. Galis,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[87]  F. Fauvel-Lafève,et al.  Microfibrils from the arterial subendothelium. , 1999, International review of cytology.

[88]  D. Brenner,et al.  Far upstream regulatory elements enhance position-independent and uterus-specific expression of the murine alpha1(I) collagen promoter in transgenic mice. , 1999, Gene expression.

[89]  A. Clowes,et al.  Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[90]  R. Reed,et al.  Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. , 1993, Physiological reviews.

[91]  D H Blankenhorn,et al.  A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1992, Circulation.

[92]  T. Matsubara,et al.  Basement membrane thickening of postcapillary venules and capillaries in rheumatoid synovium. Immunoelectron microscopic and electron microscopic morphometric analysis. , 1987, Arthritis and rheumatism.

[93]  Julie H. Campbell,et al.  Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[94]  R. Jaenisch,et al.  Embryonic lethal mutation in mice induced by retrovirus insertion into the α1(I) collagen gene , 1983, Nature.

[95]  R. Jaenisch,et al.  Embryonic lethal mutation in mice induced by retrovirus insertion into the alpha 1(I) collagen gene. , 1983, Nature.

[96]  S Udenfriend,et al.  Increased turnover of arterial collagen in hypertensive rats. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[97]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .